top of page

NDI warning letters fuel criticism of FDA enforcement approach—again

Josh Long

Jun 1, 2022

Former FDA officials and lawyers who advise clients on FDA regulations weigh in on a recent batch of warning letters targeting new dietary ingredients marketed in supplements.

bottom of page